Literature DB >> 18357765

Group B coxsackievirus virulence.

S Tracy1, C Gauntt.   

Abstract

That which is understood of virulence phenotypes in the picornaviruses derives in large part from studies of artificially attenuating phenotypes rather than through examination of naturally occurring virus strains. The CVB replicate well in a variety of different murine and human cell cultures, making them excellent viruses with which to engage the problem of how the host environment interacts with specific viral genetics to promote varying efficiencies of viral replication. It is not known how highly virulent CVB strains may arise but evidence suggests such strains are not the norm.

Entities:  

Mesh:

Year:  2008        PMID: 18357765     DOI: 10.1007/978-3-540-75546-3_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  17 in total

1.  Coxsackievirus B3 mutator strains are attenuated in vivo.

Authors:  Nina F Gnädig; Stéphanie Beaucourt; Grace Campagnola; Antonio V Bordería; Marta Sanz-Ramos; Peng Gong; Hervé Blanc; Olve B Peersen; Marco Vignuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

2.  Phylogenetic patterns of human coxsackievirus B5 arise from population dynamics between two genogroups and reveal evolutionary factors of molecular adaptation and transmission.

Authors:  Cécile Henquell; Audrey Mirand; Jan Richter; Isabelle Schuffenecker; Blenda Böttiger; Sabine Diedrich; Elena Terletskaia-Ladwig; Christina Christodoulou; Hélène Peigue-Lafeuille; Jean-Luc Bailly
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

3.  The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.

Authors:  Joshua D Yoder; Javier O Cifuente; Jieyan Pan; Jeffrey M Bergelson; Susan Hafenstein
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

4.  Dynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis.

Authors:  Rui Gu; Anae Shampang; Andrew Reilly; Dusti Fisher; William Glass; Arlene I Ramsingh
Journal:  Virology       Date:  2012-03-11       Impact factor: 3.616

5.  Proteasome activator REGgamma enhances coxsackieviral infection by facilitating p53 degradation.

Authors:  Guang Gao; Jerry Wong; Jingchun Zhang; Ivy Mao; Jayant Shravah; Yan Wu; Allen Xiao; Xiaotao Li; Honglin Luo
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

6.  Characterization of a putative ancestor of coxsackievirus B5.

Authors:  Maria Gullberg; Conny Tolf; Nina Jonsson; Mick N Mulders; Carita Savolainen-Kopra; Tapani Hovi; Marc Van Ranst; Philippe Lemey; Susan Hafenstein; A Michael Lindberg
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

7.  Coxsackie B2 Virus Infection Causing Multiorgan Failure and Cardiogenic Shock in a 42-Year-Old Man.

Authors:  Kali A Hopkins; Mahmoud H Abdou; M Azam Hadi
Journal:  Tex Heart Inst J       Date:  2019-02-01

8.  Packaging limits and stability of HIV-1 sequences in a coxsackievirus B vector.

Authors:  John P Miller; Yongzhi Geng; Hwee L Ng; Otto O Yang; Paul Krogstad
Journal:  Vaccine       Date:  2009-05-03       Impact factor: 3.641

9.  Coxsackievirus-induced acute neonatal central nervous system disease model.

Authors:  Lulu Wang; Changyuan Dong; Dong-E Chen; Zhen Song
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

10.  Visceral pathology of acute systemic injury in newborn mice on the onset of Coxsackie virus infection.

Authors:  Lulu Wang; Changyuan Dong; Dong-E Chen; Zhen Song
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.